Cell function experiments confirmed that the inhibition of METTL14 could repress the proliferation, migration, and invasion of glioma cells, while the inhibition of ASS1 might partially resist the cancer-promoting effects of METTL14. The gene discussed is METTL14; the disease is central nervous system cancer.